Every claim of mechanism, pharmacokinetics or efficacy on the Site ties back to one of the sources below. This index is updated as new articles are published and as new studies are added to active reviews.
Incretin / GLP-1
- Drucker DJ, Holst JJ. Diabetologia (2023). 10.1007/s00125-023-05906-7, PMID 37083969.
- Knerr PJ, et al. Endocrine Reviews (2022). 10.1210/endrev/bnac018, PMID 35452521.
- Lau J, et al. J. Med. Chem. (2015). 10.1021/acs.jmedchem.5b00726, PMID 26308095.
- Coskun T, et al. Mol Metab (2018). 10.1016/j.molmet.2018.09.009, PMID 30287077.
- Wilding JPH, et al. NEJM (2021). 10.1056/NEJMoa2032183, PMID 33567185.
Tissue repair (BPC-157, TB-500)
- Sikiric P, et al. Curr Pharm Des (2020). 10.2174/1381612826666200727153053, PMID 32543353.
- Goldstein AL, et al. Expert Opin Biol Ther (2012). 10.1517/14712598.2012.707195, PMID 22817334.
Growth hormone axis
- Sigalos JT, Pastuszak AW. Sex Med Rev (2018). 10.1016/j.sxmr.2017.10.001, PMID 29074011.
- Khorram O, et al. J Clin Endocrinol Metab (1997). 10.1210/jcem.82.5.3925, PMID 9141555.
Longevity (epithalon, NAD+, senolytics)
- Anisimov VN, Khavinson VK. Biogerontology (2010). 10.1007/s10522-009-9248-9, PMID 19830585.
- Pickkers P, et al. Cell (2017). 10.1016/j.cell.2017.02.031, PMID 28340339.
- Verdin E. Science (2015). 10.1126/science.aac4854, PMID 26785480.
Cosmetic peptides
- Pickart L, Margolina A. Int J Mol Sci (2018). 10.3390/ijms19071987, PMID 29986495.
Formulation & stability
- Manning MC, et al. Pharm Res (2010). 10.1007/s11095-009-0045-6, PMID 20143256.
- Wang W. Int J Pharm (1999). 10.1016/S0378-5173(99)00152-0, PMID 10448161.
- Frokjaer S, Otzen DE. Nat Rev Drug Discov (2005). 10.1038/nrd1695, PMID 15775985.